Healthcare Pharmaceutical Biotech

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

May 14, 2026 4:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2026. First Quarter 2026 and Recent Financial and Operating Highlights Generated revenue of $3.2 million for the first quarter 2026 compared to $3.6 million...

Read more

Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

May 14, 2026 3:05 PM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it has executed a non-binding letter of intent ("LOI") to acquire WellCare Today. The proposed transaction structure includes a structured cash payment of $3 million, with the balance to be satisfied through a performance-based earnout issued in preferred stock. WellCare Today is a...

Read more

CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday

May 14, 2026 2:00 PM

As a federal judge prepares to rule on the legality of the Centers for Medicare & Medicaid Services' (CMS) cannabinoid access program, newly surfaced public statements from industry participants are intensifying scrutiny surrounding the entire initiative. At issue is the CMS Substance Access Beneficiary Engagement Incentive (BEI) program, currently under review in: Smart Approaches to Marijuana et al. v. Robert F. Kennedy Jr. et al. Case No....

Read more

ALYZE Prepares to Open Utah's First Facility Where Your Gym, Doctor, Lab, and Recovery are All Under One Roof

May 14, 2026 2:00 PM

Most health-conscious professionals are managing their wellbeing across five different locations. A gym that has never seen the bloodwork. A hormone specialist who has no idea what the fitness plan looks like. A recovery studio operating completely independently from the functional medicine doctor on the other side of town. A lab that sends results into a void with no one to interpret them in the context of everything else. ALYZE was built...

Read more

Hippocratic Cancer Research Foundation Announces Two Signature Chicago Fundraising Events: "Sail and Soiree" Fashion Show and "Golden Hour for Good" Rooftop Party

May 14, 2026 1:55 PM

The Hippocratic Cancer Research Foundation, a Chicago-based 501(c)(3) nonprofit dedicated to advancing cancer research, today announced two signature fundraising events taking place in Chicago during the week of June 18, 2026: the HCRF Annual Fashion Show, "Sail and Soiree," and "Golden Hour for Good," the HCRF Young Professionals Board rooftop party. Event details, tickets, and sponsorship information are available for both June 2026...

Read more

The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Reality Check

May 14, 2026 11:00 AM

Black Book Research today released findings from The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Test, a European provider survey evaluating how electronic health record vendors help healthcare organizations convert clinical information into trusted, governed, interoperable and actionable data. The 2026 study surveyed 662 healthcare IT leaders and EHR users across eight major European EMR adoption markets: the United...

Read more

Desert Oasis Healthcare's "The Pulse" TV Show Wins Platinum Viddy Award for Alzheimer's Episode

May 14, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) has received a Platinum Viddy Award for its Season 2 episode of The Pulse titled "Loving Someone Who No Longer Knows You: The Reality of Alzheimer's", hosted by Emmy Award-winning Journalist Bianca Rae. The episode explored the emotional realities faced by patients, caregivers, and families navigating Alzheimer's disease. Through personal storytelling, expert insight, and compassionate reporting, the episode aimed...

Read more

NCQA Receives Grant from the Helmsley Charitable Trust to Advance High-Quality Diabetes Care

May 14, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) is proud to announce new funding from The Leona M. and Harry B. Helmsley Charitable Trust to strengthen clinician and health plan accountability for delivering high‑quality diabetes care. The three‑year initiative will advance quality of care for people living with type 1 and type 2 diabetes through developing new HEDIS®[1] diabetes measures, innovating approaches that capture clinical...

Read more

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026 9:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its wholly owned subsidiary Cana Laboratories, it is pursuing a strategic research and development (R&D) financing program with the European Investment Bank (EIB), the financing arm of the European Union and one of the world's largest multilateral lenders. In connection with this...

Read more

CVS Health: All Rhode Island CVS Pharmacy(R) Locations Now Accept WIC for Infant Formula

May 14, 2026 9:00 AM

CVS Pharmacy® (NYSE:CVS) announced that all 56 locations in Rhode Island are now authorized to accept the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) for infant formula purchases, marking the first time all CVS Pharmacy stores in any state are approved for the program. This statewide authorization reflects CVS Pharmacy's ongoing commitment to meeting customers where they are, reinforcing the company's focus on...

Read more

Dr. Anurag Agarwal Shares Insights on Improving Outcomes with Revision Facelift Surgery

May 14, 2026 9:00 AM

Dr. Anurag Agarwal, double board-certified facial plastic surgeon and medical director of Aesthetic Surgery Center in Naples, FL, is sharing clinical insights on revision facelift surgery, a subspecialty that requires a different level of surgical planning than a primary procedure. Revision cases involve working within tissue that has already been surgically altered, which means the anatomy, scarring, and structural support differ from patient...

Read more

MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2

May 14, 2026 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), today announced positive unblinded results from its completed Phase 1 clinical trial evaluating Ketamir-2, the Company's proprietary selective oral NMDA receptor modulator. The randomized, double-blind, placebo-controlled Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of orally administered Ketamir-2 in healthy volunteers across single ascending dose...

Read more

Praia Health Joins the Microsoft for Startups Pegasus Program to Accelerate Innovation and Growth

May 14, 2026 8:00 AM

Praia Health, a leading innovator in patient experience orchestration for health systems, is excited to announce our acceptance into the Microsoft for Startups Pegasus Program. This collaboration provides Praia with access to powerful AI tools, Microsoft Azure credits, and a global customer network to help scale faster and smarter. For health systems, the timing couldn't be more urgent. Patients today expect consumer-grade digital experiences,...

Read more

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

May 14, 2026 8:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update highlighting the Company's ongoing strategic transformation and execution progress. The first quarter of 2026 marked the beginning of a significant...

Read more

Israel's Digital Health Stress Test: AI, Cybersecurity, and Wartime Care Redefine the 2026 Healthcare IT Market

May 14, 2026 7:10 AM

Black Book Research today announced the release of State of Digital Healthcare IT 2026: Israel, a new market intelligence report examining one of the world's most digitally advanced and operationally pressured healthcare IT environments. The report finds that Israel is no longer a first-wave digitization market. Core electronic medical records, HMO-based longitudinal patient data, digital patient portals, national health information exchange,...

Read more

L Catterton, LVMH’s Investment Arm, Forms Strategic Partnership with Saint Bella Group to Fast Track Global Brand Growth

May 14, 2026 6:30 AM

Saint Bella Group recently announced that its investment in and entered a strategic partnership with L Catterton, the leading consumer-focused private equity firm affiliated with LVMH. Managing roughly $40 billion in equity capital and with investments in over 300 renowned consumer brands worldwide, L Catterton will collaborate with Saint Bella on technology innovation, international expansion, and the development of a premium brand ecosystem....

Read more

Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market

May 14, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced the next installment of its investor webinar series, "Fifth Friday at Four," scheduled for Friday, May 29, 2026 at 4:00 p.m. Eastern Time. The May investor webinar will provide investors with a comprehensive look at one of the most dynamic and rapidly...

Read more

PLAS-LABS Simplifies Scientific Validation With Automated Citation Tracking Powered by Bioz

May 14, 2026 4:00 AM

Bioz, Inc. a leading platform for uniting scientific validation with researcher's product experience, is pleased to continue its collaboration with PLAS-LABS, a trusted provider of glove boxes and controlled environment enclosures designed to support a wide range of laboratory and research applications. Through the implementation of Bioz Badges, PLAS-LABS is enabling researchers to seamlessly access publication data tied directly to its...

Read more

Luna Acupuncture & Wellness Expands Natural Support for Type 2 Diabetes Patients Across Oregon

May 14, 2026 3:35 AM

Luna Acupuncture & Wellness is expanding its focus on Type 2 diabetes care as more Oregonians search for supportive, non-invasive ways to improve their overall health and quality of life. With clinics in Astoria and Beaverton /Hillsboro, the practice is seeing increased interest from patients looking to manage fatigue, inflammation, circulation issues, stress, and chronic discomfort commonly associated with diabetes. Founded in 2015 by Dr. James...

Read more

HeroMD 4-MAX Review 2026: The Four-Ingredient Sublingual ED Prescription Designed to Skip the Wait - Vardenafil, Sildenafil, Tadalafil, and Apomorphine Explained

May 13, 2026 9:30 PM

Advertorial Disclosure: This article is for informational purposes only and does not constitute medical advice. A commission may be earned if you consult or purchase through links in this article, at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. HeroMD 4-MAX is a compounded prescription medication available only after review and approval by a licensed healthcare provider....

Read more